Katleen Janssens onbezoldigd medewerker Publicaties Katleen Janssens Diagnostic yield and clinical impact of prenatal whole exome sequencing (WES) : four-year single center experience Bron Journal of perinatal medicine - ISSN 0300-5577- (2025) p. Auteur(s) Katleen Janssens, Marjan De Rademaker, Joke…

Karen Fransis onbezoldigd medewerker Publicaties Karen Fransis Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer Bron BJU international - ISSN 1464-4096- (2025) p. Auteur(s) Lies van den Eynde, Piet Ost, Wesley Verla, Wouter Everaerts,…

Christof Vulsteke onbezoldigd gastprofessor Publicaties Christof Vulsteke Enfortumab vedotin plus pembrolizumab in untreated locally advanced or metastatic urothelial carcinoma : 2.5-year median follow-up of the phase III EV-302/KEYNOTE-A39 trial Bron Annals of oncology - ISSN 0923-7534-36:10 (2025)…

Xuan Bich Trinh onbezoldigd gastprofessor Publicaties Xuan Bich Trinh Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial Bron Gynecologic oncology - ISSN 0090-8258-191 (2024) p. 275-286 Aut…

Katleen Janssens unpaid staff Publications Katleen Janssens Diagnostic yield and clinical impact of prenatal whole exome sequencing (WES) : four-year single center experience Source Journal of perinatal medicine - ISSN 0300-5577- (2025) p. Author(s) Katleen Janssens, Marjan De Rademaker, Joke Muys, …

Christian Rolfo onbezoldigd gastprofessor Publicaties Christian Rolfo A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers Bron BJC Reports - ISSN 2731-9377-3:1 (2025) p. 1-9 Auteur(s) Peter Gallagher, Christian Rolfo, Elena …

Jan Van Den Brande onbezoldigd medewerker Publicaties Jan Van Den Brande Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004) : a phase 2 multicenter clinical trial Bron Journal for ImmunoTherapy of Cancer - ISSN 2051-1426-13:5 (2025) p. 1-10 Aut…

Steven Van Laere professor - project coordinator Research Steven Van Laere Research team Center for Oncological Research (CORE) Expertise Translational Cancer Research, particularly involving the study of human material (i.e. blood, tissue and single cells) using high-throughput profiling technologi…

Christof Vulsteke unpaid guest prof. Publications Christof Vulsteke Enfortumab vedotin plus pembrolizumab in untreated locally advanced or metastatic urothelial carcinoma : 2.5-year median follow-up of the phase III EV-302/KEYNOTE-A39 trial Source Annals of oncology - ISSN 0923-7534-36:10 (2025) p. …

Karen Fransis unpaid staff Publications Karen Fransis Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer Source BJU international - ISSN 1464-4096- (2025) p. Author(s) Lies van den Eynde, Piet Ost, Wesley Verla, Wouter Everaerts, Karen …

Ana Regina de Abreu predoc researcher FWO Research Ana Regina de Abreu Research team Medical Genetics (MEDGEN) Towards individualized treatment prediction and real-time follow-up of metastatic colorectal cancer patients using methylation biomarkers. 01/11/2021 - 31/10/2026 Abstract Colorectal cancer…

Center for Oncological Research search menu search content Publications Delayed accurate diagnosis of emerging disease outbreaks, the example of nodding syndrome Source Clinical microbiology and infection - ISSN 1198-743X-31:10 (2025) p. 1-2 Author(s) Robert Colebunders, Amber Hadermann, Charlotte L…

Yentl Van Rymenant unpaid staff Research Yentl Van Rymenant Research team Medical Biochemistry Development of tools and methods for the evaluation of FAP as a predictive/prognostic biomarker in cancer. 01/11/2019 - 31/10/2023 Abstract Immunotherapy shows great potential in the treatment of cancer. U…

Annelies Verbiest onbezoldigd medewerker Publicaties Annelies Verbiest Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors : should we treat beyond two years? Bron Acta oncologica - ISSN 0284-186X-64 (2025) p. 979-988 Auteur(s) Alexander …

Xuan Bich Trinh unpaid guest prof. Publications Xuan Bich Trinh Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial Source Gynecologic oncology - ISSN 0090-8258-191 (2024) p. 275-286 Author(…

Kim Caluwaerts onbezoldigd medewerker Publicaties Kim Caluwaerts WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors : type 1 T-lymphocyte responses are associated with clinical outcome Bron Jo…

Jan Van Den Brande unpaid staff Publications Jan Van Den Brande Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004) : a phase 2 multicenter clinical trial Source Journal for ImmunoTherapy of Cancer - ISSN 2051-1426-13:5 (2025) p. 1-10 Author(s) …

Christian Rolfo unpaid guest prof. Publications Christian Rolfo A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers Source BJC Reports - ISSN 2731-9377-3:1 (2025) p. 1-9 Author(s) Peter Gallagher, Christian Rolfo, Elena Elez…

Sasha libbrecht onbezoldigd medewerker Publicaties Sasha libbrecht PSMA-positive bone lesions unmasked : systemic mastocytosis mimicking metastatic prostate cancer Bron European journal of nuclear medicine and molecular imaging - ISSN 1619-7070- (2025) p. Auteur(s) Ine Van Thielen, Rosina Dewaide, M…

Jeroen Hendriks associate professor Research Jeroen Hendriks Research team Antwerp Surgical Training, Anatomy and Research Centre (ASTARC) Expertise Since 1995 I am involved in researchlines of the ASTARC group. This research has focussed on innovative surgical techniques for the treatment of lung m…

Yannick Verhoeven onbezoldigd medewerker Publicaties Yannick Verhoeven Targeting hedgehog signaling in pancreatic ductal adenocarcinoma Bron Pharmacology and therapeutics - ISSN 0163-7258-236 (2022) p. Auteur(s) Delphine Quatannens, Yannick Verhoeven, Peter André Van Dam, Filip Lardon, Hans Prenen,…

Michiel Beyens onbezoldigd medewerker Publicaties Michiel Beyens PSMA-positive bone lesions unmasked : systemic mastocytosis mimicking metastatic prostate cancer Bron European journal of nuclear medicine and molecular imaging - ISSN 1619-7070- (2025) p. Auteur(s) Ine Van Thielen, Rosina Dewaide, Mic…

Celine Civati predoc researcher FWO Research Celine Civati Research team Physiopharmacology (PHYSPHAR) Understanding the Effects of Heart Failure Treatments on Cancer Growth. 01/11/2023 - 31/10/2027 Abstract Heart failure (HF) and cancer are the two most common causes of death. An increasing number …

Stijn De Schepper onbezoldigd medewerker Publicaties Stijn De Schepper From SPECT/CT towards absolute quantification? The case of unilateral condylar hyperplasia of the mandible Bron EJNMMI physics - ISSN 2197-7364-11:1 (2024) p. 1-16 Auteur(s) Stijn De Schepper, Gopinath Gnanasegaran, Wouter De Vos…

Marc Peeters gewoon hoogleraar Publicaties Marc Peeters Highlights in gastro-intestinal cancer Bron Belgian journal of medical oncology - ISSN 1784-7141-12 (2018) p. 182-188 Auteur(s) M. Rasschaert, L. Triest, J. Van den Brande, K. Papadimitriou, Hans Prenen, Marc Peeters Citatielink Real-world stud…